These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 9015212

  • 1. Increased G-CSF responsiveness of bone marrow cells from hematopoietic cell phosphatase deficient viable motheaten mice.
    Tapley P, Shevde NK, Schweitzer PA, Gallina M, Christianson SW, Lin IL, Stein RB, Shultz LD, Rosen J, Lamb P.
    Exp Hematol; 1997 Feb; 25(2):122-31. PubMed ID: 9015212
    [Abstract] [Full Text] [Related]

  • 2. Macrophages from motheaten and viable motheaten mutant mice show increased proliferative responses to GM-CSF: detection of potential HCP substrates in GM-CSF signal transduction.
    Jiao H, Yang W, Berrada K, Tabrizi M, Shultz L, Yi T.
    Exp Hematol; 1997 Jul; 25(7):592-600. PubMed ID: 9216734
    [Abstract] [Full Text] [Related]

  • 3. The SH2 domain-containing protein tyrosine phosphatase SHP-1 is induced by granulocyte colony-stimulating factor (G-CSF) and modulates signaling from the G-CSF receptor.
    Ward AC, Oomen SP, Smith L, Gits J, van Leeuwen D, Soede-Bobok AA, Erpelinck-Verschueren CA, Yi T, Touw IP.
    Leukemia; 2000 Jul; 14(7):1284-91. PubMed ID: 10914554
    [Abstract] [Full Text] [Related]

  • 4. T cell developmental defects in 'viable motheaten' mice deficient in SHP-1 protein-tyrosine phosphatase. Developmental defects are corrected in vitro in the presence of normal hematopoietic-origin stromal cells and in vivo by exogenous IL-7.
    Christianson SW, Greiner DL, Deluca D, Leif J, Phillips NE, Hayes SM, Hayashi S, Joliat MJ, Lyons BL, Shultz LD.
    J Autoimmun; 2002 Mar; 18(2):119-30. PubMed ID: 11908944
    [Abstract] [Full Text] [Related]

  • 5. Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene.
    Tsui HW, Siminovitch KA, de Souza L, Tsui FW.
    Nat Genet; 1993 Jun; 4(2):124-9. PubMed ID: 8348149
    [Abstract] [Full Text] [Related]

  • 6. Stimulation of Stat5 by granulocyte colony-stimulating factor (G-CSF) is modulated by two distinct cytoplasmic regions of the G-CSF receptor.
    Dong F, Liu X, de Koning JP, Touw IP, Hennighausen L, Larner A, Grimley PM.
    J Immunol; 1998 Dec 15; 161(12):6503-9. PubMed ID: 9862674
    [Abstract] [Full Text] [Related]

  • 7. Regulation of LIP level and ROS formation through interaction of H-ferritin with G-CSF receptor.
    Yuan X, Cong Y, Hao J, Shan Y, Zhao Z, Wang S, Chen J.
    J Mol Biol; 2004 May 21; 339(1):131-44. PubMed ID: 15123426
    [Abstract] [Full Text] [Related]

  • 8. GRK6 deficiency is associated with enhanced CXCR4-mediated neutrophil chemotaxis in vitro and impaired responsiveness to G-CSF in vivo.
    Vroon A, Heijnen CJ, Raatgever R, Touw IP, Ploemacher RE, Premont RT, Kavelaars A.
    J Leukoc Biol; 2004 Apr 21; 75(4):698-704. PubMed ID: 14704365
    [Abstract] [Full Text] [Related]

  • 9. STAT3-mediated differentiation and survival and of myeloid cells in response to granulocyte colony-stimulating factor: role for the cyclin-dependent kinase inhibitor p27(Kip1).
    de Koning JP, Soede-Bobok AA, Ward AC, Schelen AM, Antonissen C, van Leeuwen D, Löwenberg B, Touw IP.
    Oncogene; 2000 Jul 06; 19(29):3290-8. PubMed ID: 10918585
    [Abstract] [Full Text] [Related]

  • 10. The C-terminal cytoplasmic region of the granulocyte colony-stimulating factor receptor mediates apoptosis in maturation-incompetent murine myeloid cells.
    Dong F, Pouwels K, Hoefsloot LH, Rozemuller H, Löwenberg B, Touw IP.
    Exp Hematol; 1996 Feb 06; 24(2):214-20. PubMed ID: 8641344
    [Abstract] [Full Text] [Related]

  • 11. Roles of Stat3 and ERK in G-CSF signaling.
    Kamezaki K, Shimoda K, Numata A, Haro T, Kakumitsu H, Yoshie M, Yamamoto M, Takeda K, Matsuda T, Akira S, Ogawa K, Harada M.
    Stem Cells; 2005 Feb 06; 23(2):252-63. PubMed ID: 15671148
    [Abstract] [Full Text] [Related]

  • 12. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A, Arai K.
    Oncologist; 1996 Feb 06; 1(5):337-339. PubMed ID: 10388012
    [Abstract] [Full Text] [Related]

  • 13. Special Education.
    Kozutsumi H.
    Oncologist; 1996 Feb 06; 1(1 & 2):116-118. PubMed ID: 10387976
    [Abstract] [Full Text] [Related]

  • 14. Thrombopoietin enhances neutrophil production by bone marrow hematopoietic progenitors with the aid of stem cell factor in congenital neutropenia.
    Sawai N, Koike K, Mwamtemi HH, Ito S, Kurokawa Y, Sakashita K, Kinoshita T, Higuchi T, Takeuchi K, Shiohara M, Kamijo T, Higuchi Y, Miyazaki H, Kato T, Kobayashi M, Miyake M, Yasui K, Komiyama A.
    J Leukoc Biol; 2000 Jul 06; 68(1):137-43. PubMed ID: 10914501
    [Abstract] [Full Text] [Related]

  • 15. Surface expression of hemopoietic cell phosphatase fails to complement CD45 deficiency and inhibits TCR-mediated signal transduction in a Jurkat T cell clone.
    Musci MA, Beaves SL, Ross SE, Yi T, Koretzky GA.
    J Immunol; 1997 Feb 15; 158(4):1565-71. PubMed ID: 9029091
    [Abstract] [Full Text] [Related]

  • 16. Deficiency of SHP-1 protein-tyrosine phosphatase in "viable motheaten" mice results in retinal degeneration.
    Lyons BL, Smith RS, Hurd RE, Hawes NL, Burzenski LM, Nusinowitz S, Hasham MG, Chang B, Shultz LD.
    Invest Ophthalmol Vis Sci; 2006 Mar 15; 47(3):1201-9. PubMed ID: 16505059
    [Abstract] [Full Text] [Related]

  • 17. Granulocyte-colony stimulating factor impedes recovery from damage caused by cytotoxic agents through increased differentiation at the expense of self-renewal.
    van Os R, Robinson S, Sheridan T, Mauch PM.
    Stem Cells; 2000 Mar 15; 18(2):120-7. PubMed ID: 10742384
    [Abstract] [Full Text] [Related]

  • 18. Phosphatidylinositol 3'-kinase and SH2-containing inositol phosphatase (SHIP) are recruited by distinct positive and negative growth-regulatory domains in the granulocyte colony-stimulating factor receptor.
    Hunter MG, Avalos BR.
    J Immunol; 1998 May 15; 160(10):4979-87. PubMed ID: 9590246
    [Abstract] [Full Text] [Related]

  • 19. Absence of CD5 dramatically reduces progression of pulmonary inflammatory lesions in SHP-1 protein-tyrosine phosphatase-deficient 'viable motheaten' mice.
    Joliat MJ, Lang PA, Lyons BL, Burzenski L, Lynes MA, Yi T, Sundberg JP, Shultz LD.
    J Autoimmun; 2002 Mar 15; 18(2):105-17. PubMed ID: 11908943
    [Abstract] [Full Text] [Related]

  • 20. Aberrant regulation of bone trace elements in motheaten and osteopetrosis mutant mice.
    Yamada G, Nakamura S, Haraguchi R, Sakai M, Suzuki K, Miyado K, Hasuwa H, Ogino Y, Minami T, Tohno Y, Blum M, Shultz LD.
    Cell Mol Biol (Noisy-le-grand); 1998 Mar 15; 44(2):315-9. PubMed ID: 9593582
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.